Table 4.
Hospitalization and follow-up outcomes.
| Characteristics | Patient #1 | Patient #2 | Patient #3 | Patient #4 | Patient #5 |
|---|---|---|---|---|---|
| Hospitalization outcomes | |||||
| Death | No | No | No | No | No |
| Major adverse cardiovascular events | No | No | No | No | No |
| Stroke | No | No | No | No | No |
| Life-threatening/major bleeding | No | No | No | No | No |
| Major vascular complication | No | No | No | No | No |
| Acute kidney injury stage 2 or 3 | Yes | No | Yes | No | No |
| Permanent pacemaker implant | No | No | No | No | No |
| Extubating time, days | 3 | 1 | 3 | 1 | 1 |
| ICU stay, days | 4 | 1 | 6 | 1 | 2 |
| Hospitalization stay, days | 6 | 7 | 22 | 14 | 13 |
| Follow-up outcomes | |||||
| Death | No | No | No | No | No |
| Major adverse cardiovascular events | No | No | No | No | No |
| NYHA functional class | II | I | II | II | III |
| Left ventricular ejection fraction,% | 56 | 52 | 42 | 55 | 56 |
| Mitral valve peak velocity, m/s | 1.3 | 1.5 | 1.2 | 1.6 | 1.1 |
| Mean mitral valve pressure gradient, mmHg | 3 | 3 | 2 | 3 | 2 |
| Mean left ventricular outflow tract pressure gradient, mmHg | 2 | 3 | 1 | 2 | 1 |
| Left atrial left–right diameter, mm | 53.43 | 51.18 | 57.20 | 51.65 | 50.71 |
| Left ventricular diameter, mm | |||||
| End-diastolic left ventricle diameter (long axis) | 63.89 | 81.17 | 71.23 | 79.88 | 70.33 |
| End-diastolic left ventricle diameter (short axis) | 43.65 | 48.37 | 44.79 | 54.50 | 51.62 |
| Left–right diameter | 43.70 | 49.63 | 45.41 | 53.92 | 52.08 |
ICU, intensive care unit; NYHA, New York Heart Association.